Brian’s Story: Finding a Treatment for Type 1 Gaucher
![](https://images.forwardcdn.com/image/970x/center/images/cropped/clinic-doctor-health-hospital-1479924563.jpg)
Brian Berman is president and chief executive officer of the National Gaucher Foundation (NGF). Diagnosed at the age of 4 with Type 1 Gaucher disease after suffering critical and worsening symptoms, Mr. Berman’s initial prognosis was grim. His parents refused to watch their son die without a fight. They found Dr. Roscoe Brady, who was then leading groundbreaking research on Gaucher disease treatment. Mr. Berman, an ideal clinical trial candidate, became the first person in the world to successfully receive enzyme replacement therapy for Gaucher disease.
A message from our editor-in-chief Jodi Rudoren
![](https://forward.com/wp-content/uploads/2024/07/Jodi-Headshot.jpg)
We're building on 127 years of independent journalism to help you develop deeper connections to what it means to be Jewish today.
With so much at stake for the Jewish people right now — war, rising antisemitism, a high-stakes U.S. presidential election — American Jews depend on the Forward's perspective, integrity and courage.
— Jodi Rudoren, Editor-in-Chief